amrinone has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, WR; Morray, JP; Powers, K; Soltow, LO | 1 |
| Alousi, AA; Evans, DB; Grant, AM; Harris, AL; Silver, PJ | 1 |
| Levy, JH; Salmenperä, M | 1 |
3 other study(ies) available for amrinone and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Amrinone reduces pulmonary vascular resistance elevated by U46619 in isolated perfused lungs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Animals; Blood Gas Analysis; Blood Pressure; Body Water; Carbon Dioxide; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Oxygen Consumption; Perfusion; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rabbits; Vascular Resistance | 1991 |
Differential vasorelaxant effects of milrinone and amrinone on contractile responses of canine coronary, cerebral, and renal arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Animals; Cerebral Arteries; Coronary Vessels; Dinoprost; Dogs; Female; In Vitro Techniques; Isoproterenol; Male; Milrinone; Muscle Relaxation; Muscle, Smooth, Vascular; Nimodipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Renal Artery; Sodium Nitrite | 1989 |
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |